This role at Moderna involves leading the global medical affairs strategy for their oncology portfolio, from early development through commercialization. The Senior Director will be responsible for integrated evidence planning, medical governance, scientific thought leadership, and extensive engagement with internal and external stakeholders to drive the success of Moderna's mRNA oncology programs. This is a high-impact position for a strategic thinker and leader in oncology, contributing to global health initiatives.
Own and lead the global medical strategy across Moderna’s oncology portfolio, ensuring seamless integration from early development to lifecycle management.,Serve as final medical accountability for assigned oncology programs, including delivery of the integrated medical plan.,Drive medical leadership in governance bodies and cross-functional decision-making forums, ensuring alignment between development, regulatory, and commercial functions.,Lead the Development Integrated Evidence Team to build comprehensive data packages for regulators, payers, and other stakeholders.,Act as global medical lead in interactions with health authorities and payers, providing strategic input and medical representation.,Direct a cross-functional global medical matrix team (Scientific Communications, Field Medical, Patient Advocacy), ensuring timely execution of deliverables.,Lead global launch readiness for oncology assets, including medical training, evidence generation, scientific engagement, and narrative development.,Build partnerships with global, regional, and national thought leaders to shape best practices and influence health policy.,Develop and execute publication strategies, medical education initiatives, and real-world evidence programs to strengthen knowledge exchange.,Manage medical affairs budget and resource planning for assigned programs, aligning with broader franchise objectives.,Partner with the VP, Oncology and cross-functional stakeholders to shape the long-term medical direction and investment strategy for the franchise.,Take full ownership of the medical strategy for Moderna’s oncology assets, driving high-quality execution and accountability across complex cross-functional landscapes.,Engage with Moderna’s digitally integrated ecosystem and leverage AI-powered data tools to support evidence generation, decision-making, and medical excellence.
MD or non-US equivalent, PharmD, or PhD with extensive oncology medical affairs leadership experience (Basic),Minimum of 15 years of experience in Medical Affairs, with a strong track record in global roles (Basic),Demonstrated leadership of global launch planning and execution in oncology or immuno-oncology settings (Basic),Deep expertise in oncology therapeutic area required (Basic),Strong strategic thinking and leadership skills in a global medical affairs role (Basic),Experience in regulatory, scientific communication, and external stakeholder engagement (Basic),Launch experience global and/or locally (Basic),Melanoma and immunotherapy experience (Preferred),Strong track record of KOL engagement, scientific communication, and external representation (Preferred),Experience navigating strategic external collaborations and cross-company governance (Preferred),Expertise in cross-functional team leadership, including pharmacovigilance, biostatistics, clinical operations, and regulatory affairs (Preferred),Strategic and operational mindset with excellent project leadership capabilities (Preferred),Comfort managing cross-functional deliverables and owning timelines and outputs at a program level (Preferred),Exceptional communication skills with the ability to translate complex science into clear, impactful messaging (Preferred),Ability to thrive in a fast-paced environment, balancing strategic leadership with hands-on execution (Preferred),A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative (Preferred)
MD, PharmD, or PhD
Must be willing to comply with U.S. export control laws; employment contingent on ability to access export-controlled information; only U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible; Moderna is unable to sponsor non-U.S. persons for an export control license.
Moderna is a biotechnology company pioneering a new class of medicines made of messenger RNA (mRNA). The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.
BerryMap uses cookies to provide essential features, analyze usage, and improve your experience. You can customize your preferences below.